Watchlist Price Alert

NewAmsterdam Pharma N.V. (NAMS)

NASDAQ: NAMS · Real-Time Price · USD

19.46

-0.29 (-1.47%)

At close: Jun 17, 2025, 10:28 AM

NewAmsterdam Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-241.6M	-176.94M	-78.05M	-28.6M	-5.75M
Depreciation & Amortization	113K	49K	72K	14K	1K
Stock-Based Compensation	33.62M	24.57M	4.12M	1.24M	n/a
Other Working Capital	-19.73M	796K	11.46M	-16.97K	-576.3K
Other Non-Cash Items	81.98M	5.23M	70.57M	-7K	306K
Deferred Income Tax	n/a	n/a	n/a	-1.44M	n/a
Change in Working Capital	-32.67M	5.87M	11.46M	3.82M	-528K
Operating Cash Flow	-158.56M	-141.22M	7.97M	-25.16M	-5.97M
Capital Expenditures	-672K	-24K	-13K	-20K	-13K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-62.18M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	728K	n/a	-112.79M
Investing Cash Flow	-62.85M	-24K	715K	-20K	-13K
Debt Repayment	n/a	n/a	747K	n/a	13.92M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-989K	8.91M	-5.79M	-15.71M	-2.6M
Financial Cash Flow	659.51M	8.91M	375.18M	68.99M	11.32M
Net Cash Flow	431.29M	-127.28M	385.43M	45.23M	5.36M
Free Cash Flow	-159.24M	-141.24M	7.96M	-25.18M	-5.98M